-
Taxonomy & unit
-
ratio: %
-
Description
-
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
-
Summary
-
Mereo BioPharma Group plc quarterly Debt-to-equity history and growth rate for Q3 2024.
- Mereo BioPharma Group plc Debt-to-equity for the quarter ending September 30, 2024 was 25.7 %.
Debt-to-equity, Quarterly (%)